56.10 USD
↘ 0.62 (1.09%)AT CLOSE (11:59 AM EDT)
Exelixis Inc
EXELNASDAQ • USD
56.65
↗ 0.55 (0.98%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
56.65
↗ 0.55 (0.98%)
Market: CLOSED
Exelixis Inc (EXEL) trades at $56.07 per share. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include a robust Altman Z-Score, exceptional Return on Equity (46.7%) and a bullish Golden Cross on the moving averages. Valuation metrics place EXEL at a fair price relative to peers.
Technical & fundamental data as of Aug 26, 2026.
Open?$56.54
High?$56.90
Low?$56.06
Prev. Close?$56.72
Volume?1.8M
Avg. Volume?2.5M
VWAP?$56.58
Rel. Volume?0.72x
Bid / Ask
Bid?$56.30 × 1.0K
Ask?$57.00 × 100
Spread?$0.70
Midpoint?$56.65
Valuation & Ratios
Market Cap?13.9B
Shares Out?247.8M
Float?243.5M
Float %?96.9%
P/E Ratio?16.15
P/B Ratio?7.54
EPS?$3.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Employees
1.1K
Market Cap
14.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2000-04-11
Address
1851 HARBOR BAY PARKWAY
ALAMEDA, CA 94502
Phone: (650) 837-7000
ALAMEDA, CA 94502
Phone: (650) 837-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?73
Short Sent.?34
Piotroski F-Score?5/9Mixed
Altman Z-Score?15.51Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?11.51%High
Short Interest?28.0M
Days to Cover?8.7
Free Float243.5M
Avg Daily Volume3.2M
Settlement Date2026-08-14
Financial Health
Current Ratio?3.46Strong
Quick Ratio?3.38Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score78/100
P/E?16.2CHEAP▾
Peers100
S&P77
P/B?7.54FAIR▾
Peers100
S&P25
P/S?5.71FAIR▾
Peers100
S&P24
P/FCF?11.9CHEAP▾
Peers100
S&P83
EV/EBITDA?13.4FAIR▾
Peers100
S&P60
EV/Sales?5.59FAIR▾
Peers100
S&P31
Returns & Efficiency
ROE?46.7%STRONG▾
Peers50
S&P91
ROA?34.5%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$1.2B
Enterprise Value?$13.6B
Fundamentals ratios updated end of day